**FR0011981968 - Common Stock **

We assign a fundamental rating of **2** out of 10 to **WLN**. **WLN** was compared to 0 industry peers in the **Unkown** industry. **WLN** has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, **WLN** is valued expensive at the moment.

*Note: WLN has only limited data available, so a full analysis was not possible, which makes the total rating unfair.*

The Piotroski-F score of **WLN** is **3.00**. This is a low score and indicates issues in the health and profitability of **WLN**.

With a **Forward Price/Earnings Ratio** of **15.02**, **WLN** is valued correctly.

When comparing the current price to the book value of **WLN**, we can conclude it is valued correctly. It is trading at **1.14** times its book value.

The **Price/Earnings Ratio** is negative for **WLN**. In the last year negative earnings were reported.

The high **PEG Ratio**, which compensates the Price/Earnings for growth, indicates **WLN** does not grow enough to justify the current Price/Earnings ratio.

Based on estimates for the next 5 years, **WLN** will show a quite strong growth in **Earnings Per Share**. The EPS will grow by **13.07%** on average per year.

Based on estimates for the next 5 years, **WLN** will show a small growth in **Revenue**. The Revenue will grow by **8.74%** on average per year.

The earnings per share for **WLN** have decreased strongly by **-576.12%** in the last year.

The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | N/A | N/A | -576.12% | 4.67% | 9.18% | 12.32% | 13.07% |

Revenue | 23.02% | 28.96% | 12.05% | 6.36% | 8.22% | 8.62% | 8.74% |

A Quick Ratio of **0.87** indicates that **WLN** may have some problems paying its short term obligations.

Based on the Altman-Z score of **0.65**, we must say that **WLN** is in the distress zone and has some risk of bankruptcy.

EPA:WLN (3/29/2023, 9:53:03 AM)**+0.34 (+0.91%) **

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap10.55B

Analysts78.33

Price Target54.82 (46.07%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)N/A

DP0.99%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)18.57%

Min EPS beat(2)18.57%

Max EPS beat(2)18.57%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

Revenue beat(2)1

Avg Revenue beat(2)1.6%

Min Revenue beat(2)1.6%

Max Revenue beat(2)1.6%

Revenue beat(4)1

Avg Revenue beat(4)-16.51%

Min Revenue beat(4)-34.61%

Max Revenue beat(4)1.6%

PT rev (1m)-0.03%

PT rev (3m)-0.85%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)2.61%

EPS NY rev (3m)2.61%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-0.11%

Revenue NY rev (3m)-0.11%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 15.02 | ||

P/S | 3.07 | ||

P/FCF | 14.89 | ||

P/OCF | 10.64 | ||

P/B | 1.14 | ||

P/tB | N/A | ||

EV/EBITDA | 14.82 |

EPS(TTM)-3.19

EYN/A

EPS(NY)2.5

Fwd EY6.66%

FCF(TTM)2.52

FCFY6.72%

OCF(TTM)3.53

OCFY9.4%

SpS12.23

BVpS32.92

TBVpS-12.29

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | N/A | ||

ROE | N/A | ||

ROIC | 2.05% | ||

ROICexc | 2.41% | ||

ROICexgc | 46.77% | ||

OM | 12.49% | ||

PM | N/A | ||

GM | 90.5% |

ROICexgc(3y)N/A

ROICexcg growth 3Y-66.55%

ROICexcg growth 5Y-54.56%

ROICexc(3y)3.31%

ROICexc growth 3Y-21.04%

ROICexc growth 5Y-32.27%

OM growth 3Y-7.54%

OM growth 5Y-8.1%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.05%

GM growth 5Y-1.43%

F-Score3

Asset Turnover0.15

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.37 | ||

Debt/FCF | 7.13 | ||

Debt/EBITDA | 5.75 | ||

Cap/Depr | 62.99% | ||

Profit Quality | N/A | ||

Current Ratio | 0.88 | ||

Quick Ratio | 0.87 | ||

Altman-Z | 0.65 |

F-Score3

WACC6.12%

ROIC/WACC7.64

Cap/Depr(3y)52.72%

Cap/Depr(5y)70.31%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

Growth

EPS 1Y-576.12%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-144.12%

EPS Next Y4.67%

EPS Next 2Y9.18%

EPS Next 3Y12.32%

EPS Next 5Y13.07%

Revenue growth 1Y12.05%

Revenue growth 3Y28.96%

Revenue growth 5Y23.02%

Revenue growth Q2Q19.25%

Revenue Next Year6.36%

Revenue Next 2Y8.22%

Revenue Next 3Y8.62%

Revenue Next 5Y8.74%

EBIT growth 1Y24.48%

EBIT growth 3Y19.24%

EBIT growth 5Y13.06%

EBIT Next Year91.98%

EBIT Next 3Y35.56%

EBIT Next 5Y25.29%

FCF growth 1Y124.1%

FCF growth 3Y53.82%

FCF growth 5Y40.5%

OCF growth 1Y121.38%

OCF growth 3Y46.33%

OCF growth 5Y34.46%

*Find stocks with similar Fundamental rating on the EuroNext*